Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:05:46 GMT 2023
by
admin
on
Sat Dec 16 14:05:46 GMT 2023
|
Protein Type | RECEPTOR |
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
NF4ASD9FJS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
NF4ASD9FJS
Created by
admin on Sat Dec 16 14:05:46 GMT 2023 , Edited by admin on Sat Dec 16 14:05:46 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_9 | 1_29 |
1_37 | 1_44 |
1_77 | 1_109 |
1_94 | 1_121 |
1_134 | 1_172 |
1_188 | 1_195 |
1_235 | 1_266 |
1_248 | 1_278 |
1_288 | 1_326 |
1_334 | 1_342 |
1_380 | 1_414 |
1_394 | 1_426 |
1_587 | 1_624 |
1_632 | 1_639 |
1_691 | 1_720 |
1_1476 | 1_1513 |
1_1519 | 1_1526 |
1_1558 | 1_1594 |
1_1574 | 1_1606 |
1_1612 | 1_1655 |
1_1666 | 1_1673 |
1_1710 | 1_1743 |
1_1726 | 1_1755 |
1_1764 | 1_1799 |
1_1810 | 1_1816 |
1_1853 | 1_1935 |
1_1863 | 1_1887 |
1_1877 | 1_1902 |
1_1917 | 1_1947 |
1_1954 | 1_1989 |
1_1999 | 1_2006 |
1_2042 | 1_2073 |
1_2056 | 1_2085 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_72 |
N | 1_360 |
N | 1_395 |
N | 1_503 |
N | 1_541 |
N | 1_586 |
N | 1_707 |
N | 1_831 |
N | 1_911 |
N | 1_917 |
N | 1_1124 |
N | 1_1206 |
N | 1_1272 |
N | 1_1616 |
N | 1_1717 |
N | 1_1776 |
N | 1_2045 |
N | 1_2096 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUBSTRATE -> TRANSPORTER |
M6P-RECEPTOR MEDIATED UPTAKE OF rhGUS WAS EVALUATED IN GM-2784 GUS-DEFICIENT HUMAN MPS VII FIBROBLASTS. GUS ACTIVITY WAS MEASURED FOLLOWING TREATMENT WITH 0.33-13.33 nM rhGUS FOR 2 H.
BINDING
Kuptake
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|